- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06242756
Use Versus Non-use of Bladder Catheterization in Elective Cesarean Delivery
March 22, 2024 updated by: University of Calgary
A Randomized Controlled Trial of Use Versus Non-use of Bladder Catheterization in Elective Cesarean Delivery
The goal of this randomized controlled trial is to investigate the impact of routine bladder catheterization in uncomplicated cesarean sections on hospitalization time (readiness to discharge), time to ambulation, urinary retention, development of urinary tract infections, prevention of bladder injury, operating time, and patient satisfaction.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
This would be a randomized controlled trial conducted on the labour and delivery and post-partum unit at a large academic site (Foothills Medical Centre) in Calgary, Alberta.
Study recruitment of patients awaiting delivery via CS would occur either in participating prenatal clinics in Calgary or in obstetrical triage by a trained nurse research assistant.
Participants would be randomized into either a catheterized or non-catheterized group prior to their scheduled elective CS.
Allocation concealment will be ensured by using either a central computer generator for randomization if funding permits, otherwise sealed, opaque, and sequenced envelopes will be used.
Since there may be potential differences in patients with increasing parity, randomization will be stratified by parity and blocked to prevent imbalance in treatment groups.
Study Type
Interventional
Enrollment (Estimated)
140
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stephen L. Wood, MD, MSc
- Phone Number: 403-944-1438
- Email: stephen.wood@albertahealthservices.ca
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 2T9
- University of Calgary
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion criteria:
- women who are 18 years of age or older with a singleton pregnancy presenting for an elective primary or repeat CS.
Exclusion criteria:
- diagnosis of abnormal placentation including placenta previa, vasa previa, or suspected invasive disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Bladder catheterization
Patients placed in the catheterized group will have an indwelling catheter placed after anesthetic has been administered.
It would be removed at 12 hours post Cesarean section.
|
Patients placed in the catheterized group will have an indwelling catheter placed after anesthetic has been administered.
It would be removed at 12 hours post cesarean section.
|
No Intervention: Non-use of bladder catheterization
Participants in the non-catheterized group would be encouraged to empty their bladders just prior to transfer to the operating room where they will undergo surgery without an indwelling catheter.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time at readiness for discharge post-surgery
Time Frame: Prior to discharge, average of 2 days postpartum
|
Time at readiness for discharge post-surgery will be collected via a form that will be distributed to the postpartum nursing team.
|
Prior to discharge, average of 2 days postpartum
|
Time to ambulation
Time Frame: Prior to discharge, an average of 2 days postpartum
|
Time to ambulation will be collected via a form that will be distributed to the postpartum nursing team.
|
Prior to discharge, an average of 2 days postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of urinary retention
Time Frame: Prior to discharge, an average of 2 days postpartum
|
Urinary retention will be defined based on a patient's inability to spontaneously void requiring either in-and-out catheterization or placement of an indwelling catheter during the post operative course
|
Prior to discharge, an average of 2 days postpartum
|
Incidence of urinary tract infections (UTI) requiring antibiotics in the first 4 weeks postpartum
Time Frame: first 4 weeks postpartum
|
Incidence of urinary tract infections (UTI) requiring antibiotics in the first 4 weeks postpartum
|
first 4 weeks postpartum
|
Incidence of bladder injury in surgery
Time Frame: During surgery
|
Incidence of bladder injury in surgery will be collected via an electronic post-operative questionnaire filled out by the operating surgeon.
|
During surgery
|
Operating time
Time Frame: During surgery
|
Operating time will be collected via an electronic post-operative questionnaire filled out by the operating surgeon.
|
During surgery
|
Patient satisfaction as measured by the Maternal Satisfaction for Cesarean Section questionnaire (MSCS)
Time Frame: Prior to discharge, an average of 2 days postpartum
|
Patients will be asked to complete the Maternal Satisfaction for Cesarean Section questionnaire at discharge.
The minimum and maximum values are 7 and 154 and higher scores mean a better outcome.
|
Prior to discharge, an average of 2 days postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stephen L. Wood, MD, MSc, University of Calgary
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2024
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
January 19, 2024
First Submitted That Met QC Criteria
February 2, 2024
First Posted (Actual)
February 5, 2024
Study Record Updates
Last Update Posted (Actual)
March 26, 2024
Last Update Submitted That Met QC Criteria
March 22, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- REB24-0044
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section Complications
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Peking University People's HospitalNot yet recruiting
-
Aswan University HospitalCompletedCesarean Section ComplicationsEgypt
-
Gaziosmanpasa Research and Education HospitalUnknownCesarean Section ComplicationsTurkey
-
Ain Shams UniversityUnknownCesarean Section ComplicationsEgypt
-
Mohamed Abdelrady MohamedCompletedCesarean Section ComplicationsEgypt
-
McGill University Health Centre/Research Institute...Thammasat UniversityUnknownCesarean Section ComplicationsCanada
-
Cairo UniversityUnknownCesarean Section ComplicationsEgypt
Clinical Trials on Bladder catheterization
-
University of Health Sciences LahoreNot yet recruiting
-
Hamilton Health Sciences CorporationWithdrawnUrinary Tract InfectionCanada
-
Oman Medical Speciality BoardNot yet recruiting
-
Rigshospitalet, DenmarkLundbeck FoundationCompletedPostoperative Urinary Retention (POUR)Denmark
-
Fondation LenvalCompletedUrinary Tract Infection BacterialFrance
-
Washington University School of MedicineCompleted
-
Antea FoundationCompletedPain | Cancer | Breakthrough Pain | Pain Due to Certain Specified Procedures | Terminal DiseaseItaly
-
University Hospital, MontpellierRecruitingUrinary Retention | Urinary Infection | Chronic Kidney InfectionFrance
-
University Hospital, GrenobleCompleted
-
Atrium Medical CenterMaastricht UniversityUnknown